SCHEMBL12698680

SCHEMBL12698680

Nc1ccc(C(=O)N2CCN(Cc3cn[nH]c3)CC2)cc1OC(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LSS P48449 1/20 0.46
▸ SIGMAR1 Q99720 1/20 0.42
▸ TSHR P16473 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ PRKAA2 P54646 1/20 0.40
▸ STAT3 P40763 1/20 0.40
▸ MAPK14 Q16539 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20192298 0.83 KDM4E (0.46) LSSKDM4EALDH1A1PRKAA2
SCHEMBL2477262 0.80 RORC (0.53) LSSSIGMAR1MEN1KMT2APRKAA2
SCHEMBL20192521 0.79 ALDH1A1 (0.43) LSSKDM4EALDH1A1MEN1LMNA
SCHEMBL20192524 0.78 F10 (0.44) LSSKDM4EALDH1A1MEN1LMNA
SCHEMBL20192575 0.77 ALDH1A1 (0.53) TSHRKDM4EALDH1A1GAAMAPT
SCHEMBL4246868 0.76 EPHX2 (0.54) TSHRALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL20750406 0.76 PKM (0.50) SIGMAR1
SCHEMBL20192497 0.76 ALDH1A1 (0.46) LSSSIGMAR1KDM4EALDH1A1MAPT
SCHEMBL1018788 0.76 MEN1 (0.46) LSSSIGMAR1TSHRKDM4EALDH1A1
SCHEMBL12698702 0.75 HSD11B1 (0.45) ALDH1A1MEN1LMNAKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012151452-A1 PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY AGIOS PHARMACEUTICALS, INC (US) 2012-11-08 — — WO disclosed
WO-2012092442-A1 THERAPEUTIC COMPOUNDS AND COMPOSITIONS AGIOS PHARMACEUTICALS, INC. (US) 2012-07-05 — — WO disclosed
Send feedback